結核(TB)診断の世界市場2015-2019...市場調査レポートについてご紹介

【英文タイトル】Global TB Diagnostic Market 2015-2019

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07.Prevalence and Incidence Rate

08.Advances in Technology
08.1 Second-generation Nucleic Acid Detection
08.2 Next-generation Nucleic Acid Detection

09.TB Diagnostics Pipeline

10.Market Segmentation by Disease Stage
10.1 Global Latent TB Diagnostics Market
10.2 Global Active TB Diagnostics Market
10.3 Global Drug Susceptibility Tests Market

11.Geographical Segmentation
11.1 Global TB Diagnostics Market in APAC
11.1.1 India
11.2 Global TB Diagnostics Market in Americas
11.2.1 Brazil
11.3 Global TB Diagnostics Market in EMEA
11.3.1 South Africa

12.Buying Criteria

13.Market Growth Drivers

14.Drivers and Their Impact

15.Market Challenges

16.Impact of Drivers and Challenges

17.Market Trends

18.Trends and Their Impact

19.Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2013
19.2.1 Abbott Diagnostics
19.2.2 Alere
19.2.3 BD
19.2.4 Roche Diagnostics
19.3 Other Prominent Vendors

20.Key Vendor Analysis
20.1 Abbott Diagnostics
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Geographical Presence
20.1.4 SWOT Analysis
20.2 Alere
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Business Segmentation by Revenue 2013
20.2.4 Business Segmentation by Revenue 2012 and 2013
20.2.5 Geographical Segmentation by Revenue 2013
20.2.6 Business Strategy
20.2.7 Recent Developments
20.2.8 SWOT Analysis
20.3 BD
20.3.1 Key Facts
20.3.2 Business Description
20.3.3 Business Segmentation
20.3.4 Revenue Segmentation by Business
20.3.5 Segmental Revenue Comparison 2013 and 2012
20.3.6 Revenue Segmentation by Geography
20.3.7 Business Strategy
20.3.8 Key Developments
20.3.9 SWOT Analysis
20.4 Roche Diagnostics
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation by Revenue 2014
20.4.4 Business Segmentation by Revenue 2013 and 2014
20.4.5 Geographical Segmentation by Revenue 2014
20.4.6 Business Strategy
20.4.7 Recent Developments
20.4.8 SWOT Analysis

21.Other Reports in This Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Global TB Diagnostics Market 2014-2019 ($ millions)
Exhibit 3: Incidence Rate per 100,000 Individuals 2013
Exhibit 4: High-burden Countries
Exhibit 5: Product Pipeline: TB Diagnostics
Exhibit 6: Segmentation of Global Active TB Diagnostics Market 2014
Exhibit 7: Segmentation of Global TB Diagnostics Market by Disease Stage 2014
Exhibit 8: Segmentation of Global TB Diagnostics Market by Geography 2014
Exhibit 9: India: Revenue Segmentation by Entity 2012
Exhibit 10: Public Sector: Segmentation of TB Diagnostics by Revenue 2012
Exhibit 11: Private Sector: Segmentation of TB Diagnostics by Revenue 2012
Exhibit 12: Brazil: Revenue Segmentation by Entity 2012
Exhibit 13: Brazil: Common TB Diagnostic Tests and Their Cost 2012
Exhibit 14: Brazil: Segmentation of TB Diagnostic Tests by Revenue 2012-2013
Exhibit 15: South Africa: Revenue Segmentation of TB Diagnostic Tests by Entity 2012-2013
Exhibit 16: Diagnostic Tests and Costs by Sectors
Exhibit 17: South Africa: Segmentation of TB by Revenue 2012-2013
Exhibit 18: South Africa: Volume of Tests in Public Sector 2012-2013
Exhibit 19: South Africa: Volume of Tests in Private Sector 2012-2013
Exhibit 20: Key Takeaways: Abbott Diagnostics
Exhibit 21: Key Takeaways: Alere
Exhibit 22: Key Takeaways: BD
Exhibit 23: Key Takeaways: Roche Diagnostics
Exhibit 24: Abbott Diagnostics: Geographical Presence
Exhibit 25: Alere: Business Segmentation by Revenue 2013
Exhibit 26: Alere: Business Segmentation by Revenue 2012 and 2013 ($ billions)
Exhibit 27: Alere: Geographical Segmentation by Revenue 2013
Exhibit 28: Product Categorization of BD
Exhibit 29: Revenue Segmentation of BD 2013
Exhibit 30: Revenue Comparison ($ millions)
Exhibit 31: Revenue Segmentation of BD by Geography 2013
Exhibit 32: Roche Diagnostics: Business Segmentation by Revenue 2014
Exhibit 33: Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 34: Roche Diagnostics: Geographical Segmentation by Revenue 2014


【レポート販売概要】

■ タイトル:結核(TB)診断の世界市場2015-2019
■ 英文:Global TB Diagnostic Market 2015-2019
■ 発行日:2015年7月22日
■ 調査会社:Technavio
■ 商品コード:IRTNTR6506
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。